Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.41 |
| ▸ | FGF1 | P05230 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.32 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.30 |
| ▸ | G6PD | P11413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13046717 | 0.74 | F10 (0.48) | F10SERPINC1 | |
| SCHEMBL18346803 | 0.71 | F10 (0.57) | F10FGF1CA1CA2CA9 | |
| SCHEMBL17340086 | 0.71 | F10 (0.57) | F10FGF1CA1CA2CA9 | |
| SCHEMBL30786471 | 0.68 | AMDHD2 (0.39) | F10CA1CA2CA9F2 | |
| SCHEMBL13287036 | 0.68 | HPSE (0.42) | F10FGF1SERPINC1 | |
| SCHEMBL18883211 | 0.67 | F10 (0.81) | F10FGF1F2SERPINC1 | |
| SCHEMBL14665995 | 0.67 | F10 (0.81) | F10FGF1F2SERPINC1 | |
| SCHEMBL10157440 | 0.67 | F10 (0.81) | F10FGF1F2SERPINC1 | |
| SCHEMBL15199336 | 0.67 | F10 (0.81) | F10FGF1F2SERPINC1 | |
| SCHEMBL7121030 | 0.67 | LGALS8 (0.47) | F10FGF1CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838549-B2 | Linker compound, ligand conjugate, and production methods thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20070213523-A1 | Linker Compound, Ligand Conjugate, and Production Methods Thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213523-A1 | Linker Compound, Ligand Conjugate, and Production Methods Thereof | SLC7A5, SLC2A1, SLC2A9 | F10 725/4885FGF1 712/4885CA1 592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.